The decision on appeal overturns an earlier ruling by the Delhi High Court that Monsanto - which has been bought by German drug and crop chemical maker Bayer AG - was unable to claim patents on GM cotton seeds.
"This is a very good move as most international companies have stopped releasing new technology in the Indian market due to the uncertainty over patent rule," said Ajit Narde, a leader of the Shetkari Sanghatana, a farmers' body, which has been demanding access to new technologies.
Access to advanced technology was important to help Indian farmers to compete with rivals overseas, Narde said.
Mahyco Monsanto Biotech (India) (MMB), a joint venture between Monsanto and India's Maharashtra Hybrid Seeds Co (Mahyco), sells GM cotton seeds under license to more than 40 Indian seed companies, which in turn sell product to retailers.
Monsanto's Indian joint venture had terminated its contract with NSL in 2015 after a royalty payment dispute, escalating tensions over seed technology and drawing in the Indian and U.S. governments. (reut.rs/2ncBknn)
New Delhi in 2003 approved Monsanto's GM cotton seed trait, the only lab-altered crop allowed in India, as well as an upgraded variety in 2006, helping transform the country into the world's top producer and second-largest exporter of the fibre.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)